Remarkable Response to Neoadjuvant Therapy with Methotrexate, Vinblastine, Adriamycin, and Cisplatin for Undifferentiated Bladder Carcinoma: A Case Report and Literature Review

We report a case of primary undifferentiated bladder carcinoma, which revealed a remarkable response to methotrexate, vinblastine, adriamycin, and cisplatin (MVAC) therapy. A 46-year-old Japanese woman presented at the hospital with the chief complaints of gross hematuria and pain during urination....

Descripción completa

Detalles Bibliográficos
Autores principales: Numahata, Kenji, Hoshi, Senji, Hoshi, Kiyotsugu, Yasuno, Nobuhiro, Kubo, Maiko, Sasagawa, Isoji, Ohta, Shoichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Published online: November, 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264512/
https://www.ncbi.nlm.nih.gov/pubmed/25520650
http://dx.doi.org/10.1159/000369004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264512/
https://www.ncbi.nlm.nih.gov/pubmed/25520650
http://dx.doi.org/10.1159/000369004

Ejemplares similares